New study reveals cefoxitin as effective first-line treatment for intraamniotic infections Post author: Post published:February 5, 2024 Post category:uncategorized The effectiveness of Cefoxitin in the treatment of Endometritis and Intraamniotic Infections (IAI). You Might Also Like Repeated mRNA vaccines supercharge immune response against COVID-19, study finds December 7, 2023 Scientists develop new method for relocating misplaced proteins September 22, 2024 EULAR launches ENTRI initiative to boost rheumatic disease research across Europe June 16, 2024